Contraception in Patients with Liver Disease and Liver Transplant

Overview

Journal Clin Liver Dis (Hoboken)

Specialty Gastroenterology

Date 2024 Feb 21

PMID 38379765

Authors

Meera Garriga

Grace Zhang

Monika Sarkar

Affiliations

Soon will be listed here.

Abstract

1_ov26k0cyKaltura.

References

Dehlendorf C, Grumbach K, Schmittdiel J, Steinauer J . Shared decision making in contraceptive counseling. Contraception. 2017; 95(5):452-455. PMC: 5466847. DOI: 10.1016/j.contraception.2016.12.010. View

Jabiry-Zieniewicz Z, Bobrowska K, Kaminski P, Wielgos M, Zieniewicz K, Krawczyk M . Low-dose hormonal contraception after liver transplantation. Transplant Proc. 2007; 39(5):1530-2. DOI: 10.1016/j.transproceed.2007.02.063. View

de Bastos M, Stegeman B, Rosendaal F, van Hylckama Vlieg A, Helmerhorst F, Stijnen T . Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014; (3):CD010813. PMC: 10637279. DOI: 10.1002/14651858.CD010813.pub2. View

Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P . Shared decision making: a model for clinical practice. J Gen Intern Med. 2012; 27(10):1361-7. PMC: 3445676. DOI: 10.1007/s11606-012-2077-6. View

Glasier A, Cameron S, Fine P, Logan S, Casale W, Van Horn J . Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet. 2010; 375(9714):555-62. DOI: 10.1016/S0140-6736(10)60101-8. View

Parks C, Peipert J . Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC). Am J Obstet Gynecol. 2016; 214(6):681-8. PMC: 4884485. DOI: 10.1016/j.ajog.2016.02.017. View

Curtis K, Tepper N, Jatlaoui T, Berry-Bibee E, Horton L, Zapata L . U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016; 65(3):1-103. DOI: 10.15585/mmwr.rr6503a1. View

Cundy T, Cornish J, Evans M, Roberts H, Reid I . Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ. 1994; 308(6923):247-8. PMC: 2539337. DOI: 10.1136/bmj.308.6923.247. View

Sarkar M, Brady C, Fleckenstein J, Forde K, Khungar V, Molleston J . Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2020; 73(1):318-365. DOI: 10.1002/hep.31559. View

10.

Qureshy Z, Lokken R, Kakar S, Grab J, Mehta N, Sarkar M . Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study. Contraception. 2022; 119:109915. PMC: 10266542. DOI: 10.1016/j.contraception.2022.11.006. View

11.

Stringer E, Kaseba C, Levy J, Sinkala M, Goldenberg R, Chi B . A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007; 197(2):144.e1-8. PMC: 2730754. DOI: 10.1016/j.ajog.2007.03.031. View

12.

Turok D, Gero A, Simmons R, Kaiser J, Stoddard G, Sexsmith C . Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception. N Engl J Med. 2021; 384(4):335-344. PMC: 7983017. DOI: 10.1056/NEJMoa2022141. View

13.

Gomes M, Deitcher S . Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med. 2004; 164(18):1965-76. DOI: 10.1001/archinte.164.18.1965. View

14.

Cockrum R, Soo J, Ham S, Cohen K, Snow S . Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age. Obstet Gynecol. 2022; 140(3):477-487. PMC: 9669089. DOI: 10.1097/AOG.0000000000004896. View